1994) and PMP22 (Roa et al., 1993a; clinical findings, pathologic findings, and early age of onset supported a diagnosis of DSS. Patient 1040 was 1995; Valentijn et al., 1995) . Within the group of hereditary motor and sensory neuropathies (HMSN), which noted to have gross motor delay in early childhood and presented at age 8 with a severe, early onset peripheral includes CMT, HNPP, and DSS, another neuropathy, termed congenital hypomyelination (CH), has been idenneuropathy. Based on his early onset, severity of clinical presentation, and NCV findings, patient 1040 was diagtified. Congenital hypomyelination is characterized clinically by early onset in infancy of hypotonia, areflexia, nosed with DSS. Family HOU 374 (patients 1047-1050) was evaluated when both children (1047 and 1048) from distal muscle weakness, and very slow NCV (Lyon, 1969; Kennedy et al., 1977; Harati and Butler, 1985) . In its a consanguineous mating were diagnosed with DSS based on clinical presentation, physical exam, and abextreme form, it may present with severe joint contractures or arthrogryposis multiplex congenita (Charsence of NCVs. NCV findings in each parent (1049 and 1050) could be consistent with a mild CMT1 phenotype. nas et al., 1988; Boylan et al., 1992) . In less severe cases, because of the overlapping clinical presentation, it can Detailed clinical information for each patient can be found in Experimental Procedures. be extremely difficult to distinguish between CH and DSS based only on physical examination and electrophysiologic studies. However, pathologic findings on
Molecular Results
Heteroduplex analysis on a cohort of 100 unrelated pasural nerve biopsies can often differientiate between these disorders as patients with CH lack both active tients diagnosed with various demyelinating peripheral neuropathies was performed for exons 1-6 of the MPZ myelin breakdown and well-organized onion bulbs, have absence of inflammation, and show hypomyelination of gene. Several patients showed altered patterns and were further analyzed by DNA sequencing. Patient 1040 most or all fibers (Ono et al., 1982; Harati and Butler, 1985; Balestrini et al., 1991) . These features are not had a single faster migrating heteroduplex band, while patient 1022 exhibited a single slower migrating heteroprominent in DSS. While progress has been made with regard to the molecular diagnosis of CMT1 and DSS, duplex band (data not shown). Patients 1047-1050 (family HOU 374) showed a complex heteroduplex pattern there is no published data on the molecular analysis of CH.
consisting of three heteroduplex bands, one migrating below the homoduplex and two migrating above (data Mutational analysis in patients with either CMT1B, DSS, or CH has identified five novel MPZ mutations not shown). In addition, even though patients 511 and 987 were negative by heteroduplex analysis, an altered (Table 1) . These mutations provide an excellent model for understanding the etiology of these myelinopathies pattern was shown by single strand conformation polymorphism (SSCP) analysis (performed by E. N. in the and the correlation of disease type and severity with mutation type and location to derive phenotype/genolaboratory of C. V. B.) in MPZ exon 3 and exon 5, respectively (data not shown) . Heteroduplex type correlations.
analysis of the other five exons of MPZ, all four coding exons of PMP22, and the large coding exon of Cx32 detected no other base alterations, except in patient Results 511 who has a silent polymorphism in MPZ exon 6 .
Patient Diagnoses
Patient 511 presented as an adult with a moderate pe-
The precise DNA sequence alterations were identified by direct sequence determination of both sense and ripheral neuropathy. Clinical, electrophysiologic, and family history supported a diagnosis of CMT1. Patient antisense strands of the involved exons. Patient 511 has a heterozygous C→A transversion in exon 3 at nucleo-987 presented early in life with delayed motor milestones and severely reduced NCVs that indicated a generalized tide 292 that leads to an Arg-69→Ser amino acid substitution ( Figure 2C ). HhaI restriction analysis confirmed peripheral neuropathy. A sural nerve biopsy was performed to facilitate a more definitive diagnosis (Figure the presence of this mutation. Normally, HhaI cuts once within the 310 bp exon 3 polymerase chain reaction 1). Based on the clinical presentation, physical examination, electrophysiologic, and pathologic findings, patient (PCR) product to yield two fragments of 120 bp and 190 bp. However, the C→A mutation destroys the HhaI site 987 was diagnosed with CH. Patient 1022 was selfreferred at age 42 because of a persistent, but nonproand results in the presence of the 310 bp uncut product. BsaHI digestion was used as a control (data not shown). gressive unsteady gait, balance disturbance, and poor fine motor skills. Her past medical history, severity of
The base change in exon 5 of patient 987 consists of This electron micrograph shows two axons of similar size, one without myelin (a) and the other with a thin myelin sheath (b) showing stretches of noncompaction next to the axon (arrows). The axon without myelin (a) is surrounded by a Schwann cell with copious cytoplasm, which has partially wrapped the axon with a single process. Another Schwann cell without an axon is located nearby (c).
Original magnification: 25,000ϫ.
a C→T transition at nucleotide 643 that generates a seen in 100 unrelated controls, which indicates that both mutations at codon 69, in patients 511 and 1022, are premature stop in the Gln-186 codon ( Figure 2B ). The mutation results in the elimination of a BsoFI restriction disease associated and not common polymorphisms. The mutation in patient 1040 occurs in exon 4 and site. BsoFI cuts the wild-type 210 bp exon 5 PCR product into 170 bp and 40 bp fragments. Digestion of patient consists of a heterozygous 4 bp deletion of nucleotides 521-524 that results in a frameshift after Leu-145. This 987 results in the formation of three bands: 210 bp (uncut mutant allele), 170 bp, and 40 bp (wild-type allele) (data frameshift alters the amino acid sequence of the last 74 codons and produces a protein that is one amino acid not shown). HhaI digestion was used as a control. BsoFI digestion of the parents, as well as 99 unrelated controls, longer than wild type. A deletion was identified by direct sequencing of PCR-amplified genomic DNA. However, showed only 170 bp and 40 bp fragments, which indicates that this is a disease-associated mutation. The the exact nature of the deletion could not be determined by direct sequencing because of the presence of both absence of parental mutations and confirmation of paternity demonstrates that patient 987 carries a de novo the deleted and undeleted copies in the same lane. Therefore, the exact four base pairs deleted were determutation.
Patient 1022 carries a heterozygous C→T transition mined by fluorescent automated sequencing of cloned PCR products (Figure 3 ). Parental DNA was unavailable at the same nucleotide position as patient 511; however, this mutation predicts an Arg-69→Cys amino acid subfor analysis. Direct sequence determination of exon 3 identified stitution ( Figure 2A ). Direct sequencing of both unaffected parents revealed only wild-type sequence. This the base change in family HOU 374 as a 1 bp deletion of nucleotide 306 that leads to a frameshift after the mutation was also confirmed by the HhaI digestion used for patient 511. Only patient 1022 showed the presence Gly-74 codon and a premature truncation of the protein 13 codons later. The children, 1047 and 1048, are homoof three bands when cut with HhaI (data not shown). The absence of parental mutations and confirmation of zygous for this allele as indicated by Figure 2D . The heterozygosity of the parents, 1049 and 1050, was conpaternity demonstrates that patient 1022 carries a de novo mutation. The destruction of the HhaI site was not firmed by fluorescent automated sequencing of cloned PCR products, which separately identified the wild-type paper, CH ( Figure 4 ). As mutations associated with DSS are most often found in the heterozygous state, they and mutant alleles (data not shown). The homozygosity or heterozygosity were additionally confirmed by restricrepresent dominant alleles and not recessive as originally thought (Hayasaka et al., 1993b; Roa et al., 1993a) . tion analysis. The 1 bp deletion creates a novel BslI restriction site that cuts the wild-type 330 bp exon 3
In fact, the overwhelming majority of DSS cases in which a mutation has been identified represent de novo point PCR product into 195 bp and 135 bp fragments. BsaHI digestion was used as a control. Digestion of 100 unremutations in either MPZ or PMP22. The identification of these 29 MPZ point mutations in patients with peripheral lated controls with BslI resulted in only the 330 bp wildtype band that indicates a disease-associated mutation neuropathies enables deductions regarding genotype/ phenotype correlations in these disorders. Figure 4 (data not shown).
shows the amino acid changes associated with each MPZ mutation and the corresponding clinical phenoDiscussion type. Structural studies of the rat P 0 protein (Shapiro et al., 1996) , which manitains 97% primary sequence Genotype/Phenotype Correlations To date, 29 point mutations in MPZ have been identified conservation with its human counterpart, allow predictions to be made with respect to the effects individual that result in either CMT1B, DSS, or as reported in this Amino acids are numbered based on the processed protein, and amino acid residue numbers are enclosed within parentheses. Yellow circles correspond to amino acid substitutions causing CMT1B, while the pink circles indicate amino acid substitutions associated with DSS. The delta symbol indicates an amino acid deletion (del), and the X mark indicates nonsense mutations. Frameshift (fs) mutations are indicated by a slash mark preceding the first amino acid affected in the reading frame, and the listing at the bottom indicates the last unaffected amino acid before the frameshift. Numbers 1-23 result in CMT1B (yellow). Number 12, Trp(72)Cys, and number 23, Val(203)fs, are denoted by a pink number sign to indicate that these substitutions result in a phenotype that could be more consistent with DSS than severe CMT1B. Number 5, Phe(35)del, and number 13, Gly(74)fs, are denoted by a pink *hmz sign to indicate that in the homozygous state these mutations result in a DSS phenotype. Numbers 24-28 (pink) are associated with DSS. Number 29 (blue) results in CH. References are as follows: 1 (Hayasaka et al., 1993e) ; 2 (Gabreë ls-Festen et al., 1996); 3 (Kulkens et al., 1993); 4 (Blanquet-Grossard et al., 1995); 5 (Ikegami et al., 1996); 6 (Nelis et al., 1994b; ; 7 (Himoro et al., 1993) ; 8 and 9 (Hayasaka et al., 1993a) ; 10 (Hayasaka et al., 1993d; Gabreë ls-Festen et al., 1996) ; 12 14 (Blanquet-Grossard et al., 1996); 15 (Gabreë ls-Festen et al., 1996; Tachi et al., 1996); 16 (Nelis et al., 1994a); 17, 21, and 22 (Nelis et al., 1994b) ; 18 and 20 19 (Gabreë ls-Festen et al., 1996) ; 23 (Bellone et al., 1996) ; 24 and 26 (Hayasaka et al., 1993b); 25 (Gabreë ls-Festen et al., 1996; this work); 28 (Rautenstrauß et al., 1994); 11, 13, 25, 27, and 29 (this work) . extracellular mutations may have on the processing, are consistent with our proposed model (Shapiro et al., 1996) . Two other cysteine substitutions in the extracellustructure, and protein interactions of P 0 and enable correlations with disease severity. lar domain, Tyr-53→Cys (Himoro et al., 1993) and Trp72→Cys (Latour et al., 1995) , were reported in CMT1B There are two instances wherein different mutations at the same amino acid location within P0 (positions 34 patients. While this finding appears inconsistent with our proposed mechanism, the tyrosine side chain at [Hayasaka et al., 1993b; Kulkens et al., 1993; BlanquetGrossard et al., 1995] and 69 [Hayasaka et al., 1993d;  position 53 is buried in the hydrophobic core ( Figure 5 ) (Shapiro et al., 1996) , and the substituted cysteine is Gabreë ls-Festen et al., 1996; this manuscript]) produce distinct phenotypes (CMT1B or DSS). These positionlikely unavailable to form disulfide bonds. However, the sulfhydryl group of the cysteine substitution at position specific mutations provide an excellent model for examining how disease severity correlates with mutation ef-72 is exposed ( Figure 5 ). If one considers CMT1B and DSS as similar disorders with a spectrum of severity, fect. Both DSS mutations arise from cysteine substitutions that, based on structural data, would produce outthen the description by of a patient who has an early onset of disease and an NCV of 10 wardly pointing thiols ( Figure 5 ). We postulate that these outwardly pointing thiols produce a dominant negative m/s may represent either severe CMT1 or DSS. Therefore, the severe phenotype conveyed by this mutation effect through the formation of disulfide aggregates in the extracellular space that possibly "poison" the myelin could be considered consistent with the proposed dominant negative effect of the substituted cysteine residues. structure by forming abnormal P 0 complexes that incorporate both normal and abnormal subunits and severely
The corresponding less severe CMT1B mutations, at positions 34 (Kulkens et al., 1993 ; Blanquet-Grossard et reduce the number of normal multimeric P 0 complexes. Our model of a dominant negative mechanism requires al., 1995) and 69 (Hayasaka et al., 1993d; Gabreë lsFesten et al., 1996 ; this manuscript), may constitute a multimeric P0 complex. The structural data, which suggest the formation and interaction of homotetramers, loss-of-function alleles. The deletion at position 34 (Kul-are well documented in osteogenesis imperfecta (OI), a disorder of type I collagen. OI type 1 results from heterozygous mutations in the ␣1(I) gene that prohibit incorporation of abnormal protein into the collagen molecule or reduce the amount of protein available (i.e., loss of function), thereby causing a 50% loss in the amount of normal collagen. OI type II is the most severe lethal form and is due to de novo heterozygous ␣1(I) mutations that cause the mutant collagen peptide to act in a dominant negative manner by incorporating into the multimeric collagen triple helix to cause a 75% reduction in the amount of normal collagen (Byers et al., 1991) . Therefore, dominant negative mutations in a protein involved in a multimeric complex disrupt the macromolecular structure more than heterozygous loss-of-function mutations and thus produce a more severe phenotype.
Identification of a Homozygous Mutation
Of particular interest is the identification of potentially homozygous null MPZ patients. The Gly-74 frameshift mutation in patients 1047-1050, resulting from a 1 bp deletion, leads to a premature stop that predicts a truncated protein of only 87 amino acids. This truncated protein is presumably degraded and never reaches the membrane. Therefore, this mutation is similar to the above mentioned nonsense mutations and probably constitutes a loss-of-function allele. In this family, the parents, who are heterozygous for the 1 bp deletion, have a mild neuropathy with features of CMT1. The children who are homozygous for the same 1 bp deletion, malities lead to moderate electrophysiologic alterations indicates that based on the clinical symptoms this mutation may (Martini et al., 1995b) . This demonstrates that only half represent either severe CMT or DSS.
the normal dose of P0 is sufficient to begin myelination, but apparently is not enough to support myelin maintenance at a later age. The resulting late onset and mild kens et al., 1993) falls within a ␤ strand and may disrupt its in (hydrophobic)-out (hydrophilic) alternation, causphenotype resembles the phenotype of CMT1B patients (Martini et al., 1995b) . On the other hand, P 0 Ϫ/Ϫ (null) mice ing an unstable protein. Ser-34 is near an apparent site of P 0 -P 0 homotetramer interactions. Substitution to phedevelop abnormal, poorly compacted myelin from the onset of myelin formation, probably owing to the loss nylalanine (Blanquet-Grossard et al., 1995) , which has a large hydrophobic side chain, might prevent the formaof the adhesive properties of P 0 (Martini et al., 1995b) . These P 0 -deficient mice have myelin decompaction at tion of a fully functional network of molecules, possibly resulting in a partial decrease in myelin compaction 4 days after birth that results in pronounced electrophysiologic and pathologic changes that are strikingly similar (Shapiro et al., 1996) . The histidine and serine substitutions at position 69 may disrupt the interaction between to those in severely affected CMT1B and DSS patients. Therefore, P0 heterozygous and homozygous knockout P0 proteins that is important for the formation of the homotetramer (Shapiro et al., 1996) . The identification mice are excellent models for understanding the role P0 plays in human myelination. of nonsense mutations, at positions 125 and 152 (Nelis et al., 1994b) , associated with a CMT1B phenotype, further
The presentation of the HOU 374 family is similar to that discussed by Ikegami et al. (1996) and to the homosupports the postulation that the above mentioned mutations represent loss-of-function alleles, since the rezygous 17p duplication cases reported for CMT1A (Killian and Kloepfer, 1979; Lupski et al., 1991 ; Kaku et al., sulting truncated proteins probably never reach the membrane.
1993). In each of these cases, the heterozygous parents presented with CMT1, while the homozygous children Examples of such genotype/phenotype correlations were more severely affected with DSS. The differences However, those mutations that produce a truncated product of 120 residues or longer result in a severe in clinical phenotype between heterozygous mutations (CMT1) and homozygous mutation (DSS) in both MPZ dominant ␤-thalassemia. The severity of the phenotype presumably reflects the properties of the mutant protein and PMP22 not only demonstrates the dosage sensitivity of these myelin genes, but also further supports the that allow it to still bind heme, but also resist proteolytic degradation due to secondary structure and thus allow hypothesis that these clinical "entities" represent variants of the same disease.
the mutant to form aggregates (Thein et al., 1990) . The three other intracellular mutations in MPZ are all frameshifts that generate proteins that are slightly larger Mutation Associated with CH than wild type, produce different intracellular amino acid This manuscript describes a mutation, Gln-186→stop, conformations, and manifest as severe neurological associated with the diagnosis CH (patient 987). There phenotypes. It has been shown that the highly positively has been some controversy and difficulty in differentiatcharged P 0 intracellular domain interacts with the negaing CH from DSS, since there is considerable overlap tively charged phospholipid bilayer to help form the main clinical presentation. Based on pathologic findings jor dense line (Ding and Brunden, 1994) . Posttranslaof sural nerve biopsies (the absence of active myelin tional phosphorylation of the intracellular domain may breakdown and the paucity of the onion bulbs in CH regulate its affinity for the phospholipid bilayer (Suzuki and the presence of demyelination/remyelination and et al., 1990). The fact that changing either the entire an abundance of well-organized onion bulbs in DSS intracellular conformation (i.e., the Leu-145 frameshift) [Balestrini et al., 1991] ), CH is considered to result from or only the last 16 amino acids (i.e., the Val-203 a congenital impairment in myelin formation, while DSS frameshift) produces a severe neurological phenotype is thought to be due to abberrant demyelination and suggests that even slight alterations of the charge profile subsequent remyelination of the peripheral nerve. There can interfere with the formation and compaction of the is also variation in the prognosis of patients diagnosed major dense line. This conclusion is supported by findwith CH. Harati et al. (1985) showed correlation of morings demonstrated for the myelin basic protein (MBP), bidity and mortality with the presence/absence of onion an intracellular positively charged protein capable of bulbs. Patients with few onion bulbs died in early ininteractions with phospholipid bilayers and responsible fancy, usually because of difficulty in swallowing and for the compaction of the major dense line in the CNS, respiration after birth. Patients with atypical onion bulbs, wherein small changes in the net charge markedly alsimilar to patient 987, survived but were affected with tered the interaction of the protein with the lipid and severe motor and sensory impairment (Harati and Butler, affected vesicle aggregation (Cheifetz et al., 1985; . These differences in outcome may represent ge- Cheifetz and Moscarello, 1985) . netic heterogeneity such that mutations in essential early myelin gene(s) cause a severe phenotype, while mutations in other, possibly later acting gene(s), like Conclusions MPZ, lead to a less severe outcome. Nevertheless, our CMT1, DSS, and CH represent a spectrum of genotypiobservation of a P 0 mutation associated with a CH phecally related entities resulting from mutations in a numnotype suggests that a severe allele of a major myelin ber of genes (including MPZ) involved in myelination. protein component can have dramatic effects on myelin
The phenotype is dependent upon the gene in which structure and formation. the mutations occur, the nature of the mutation, the effect the mutation has on the gene and protein product, and the consequence of that change on myelination.
Mutations Associated with the MPZ Intracellular Domain
The data presented in this manuscript support the postulation that these peripheral neuropathies are not necThere are five mutations that affect the intracellular domain of MPZ (numbers 22, 23, and 27-29 in Figure 4) . The essarily distinct pathophysiologic entities, but instead represent a spectrum of related clinical findings. Molecseverity of most of the intracellular mutations suggests it plays an important functional role for myelin. The Tyrular evaluation of patients with inherited peripheral neuropathies will not only complement the clinical, electro-152 nonsense mutation (Nelis et al., 1994b) results in a CMT1 phenotype and, as discussed earlier, probably physiologic, and pathologic findings, but will more precisely define the etiology and pathogenesis of these represents a loss-of-function allele. However, the severity of the phenotype (i.e, CH) resulting from the Gln-186 disorders.
We hypothesize that the variation in clinical severity nonsense mutation agrues that instead of a loss-offunction allele, the resulting protein maintains some caused by different mutations in MPZ can be explained by the different effects of each mutation. We propose function that interferes with the normal function of P0, in particular the formation of the major dense line. The that heterozygous loss-of-function mutations reduce the total amount of normal protein present, thus produccorrelation between placement of nonsense mutations within the protein and the severity of the disease has ing a less severe CMT1B phenotype, while dominant negative mutations, which disrupt the formation or also been documented in ␤-thalassemia. It has been shown that nonsense or frameshift mutations that proproper functioning of the P 0 complex, or homozygous loss-of-function mutations, which completely lack the duce truncated proteins that are up to 72 residues in length usually produce a mild phenotype in heterozy-P 0 protein, result in a more severe DSS or CH phenotype. Such hypotheses need to be further investigated by gotes. It is thought that these short fragments are degraded, and only half the normal ␤-globin is synthesized.
biochemical methods to determine the exact effect each ulnar nerves. A sural nerve biopsy showed a severe demyelinatingmutation has on the processing, structure, or interacremyelinating neuropathy with evidence of a mild secondary axonal tions of P0.
degeneration. Teased nerve preparations revealed changes of demyelination and remyelination involving 80% of myelinated fibers.
Experimental Procedures
There was no evidence of inflammation, and onion bulbs were identified by light microscopy of semithin sections stained with toluidine Patient Evaluations blue. A cohort of 100 unrelated patients, who carried a diagnosis of a Patient 1040 was born by Cesarean section to a family with no demyelinating peripheral neuropathy according to widely accepted history of neurological disorders. By history, he was a floppy baby. diagnostic criteria (Dyck et al., 1993) , was analyzed for mutations At 6 months, he was noted to be hypotonic, and in early childhood in three genes known to be associated with peripheral neuropathies had gross motor delay that included no head control until after 1 (MPZ, PMP22, and Cx32). All patients were found to be negative year and not walking alone until between the ages of 2 and 3. He for the CMT1A duplication on chromosome 17p11.2-p12 (Wise et was evaluated by a neurologist at 8 years of age and found to al., 1993). Patients positive for a MPZ mutation by heteroduplex have atrophy and mild weakness of the hands, marked distal leg analysis were further evaluated. The clinical findings of patients 511, weakness, absent deep tendon reflexes, and sensory loss. NCV 987, 1022, 1040, and 1047-1050 are discussed below. Given the studies showed no elicited response in the sensory nerves of the apparent de novo nature of the disease in patients 987 and 1022, median, ulnar, and left posterior tibial nerves and prolongation of DNA-based paternity testing was performed by Identigene (Housmotor latency with decreased amplitude in both the median and ton, TX) and yielded a probability of paternity of at least 99.4252% ulnar nerves. A sural nerve biopsy was deferred by the parents. and 99.99952%, respectively. Parental DNA was unavailable for paPatients 1047-1050 (family HOU 374) were evaluated when both tient 1040.
children (1047 and 1048) were diagnosed with DSS. The parents Patient 511 was self-referred because of a family history of CMT1 (1049 and 1050) are distantly related (coefficient of consanguinity: in her father and paternal grandmother and a history of "toe walking" 1/512) and were found to have a mild chronic neuropathy with feasince age 3 and "flat feet." Physical examination at age 20 revealed tures of CMT1. Based on the severity of the clinical presentation pes planus, severe distal muscle atrophy, foot drop, absent deep and the consanguineous mating, the children were suspected to be tendon reflexes, decreased sensation in the distal lower extremities, homozygous for the mutation carried by their parents. and mild distal upper extremity weakness. Electrophysiology
Patient 1048 is the first child born to 1049 and 1050. He had showed slowed NCVs (right ulnar nerve, 13 m/s; right median nerve, delayed acquisition of motor milestones (i.e., could not sit, stand, 11 m/s; unobtainable motor conductions and sensory nerve action or walk at 1 year of age). Upon examination at age 17, he was found potentials [NAP] in the lower extremities). A sural nerve biopsy was to have bilateral pes cavus, scoliosis, clawed hands, severe muscle not performed.
wasting, hypotonia, areflexia, and absent vibration sensation below Patient 987 was first evaluated by a neurologist at 10 months the shoulders. He relies upon a wheelchair for mobility because of because of delayed motor milestones. She was the product of a severely impaired strength. Nerve conduction studies demonstrated normal pregnancy and delivery and had no family history of neuroabsence of both sensory and motor action potentials. A sural nerve logical disorders. Clinical evaluation revealed mild hypotonia of the biopsy, performed at age 5, showed a hypertrophic neuropathy with limbs and trunk and absent stretch reflexes. She could not lift her onion bulb formation. There was severe thickening of the nerve, head while prone, but could sit if placed. Nerve conduction studies massive demyelination and thinning of the fibers, massive increase revealed a generalized demyelinating neuropathy (left median, 6 in the number of Schwann cells with onion bulbs, and increased m/s; right ulnar, 6 m/s), and sensory action potentials were absent. amounts of interstitial endoneural tissue. By 18 months of age, she was crawling and stood with support, by
Patient 1047 was the second child born to 1049 and 1050. He 20 months she could pull to stand, and by 3.5 years she could take had delayed acquisition of motor milestones (i.e., sat independently a few steps unassisted. Scoliosis was diagnosed at age 3. A sural at 8 months, crawled at 1 year, and walked at 3.5 years). Upon nerve biopsy performed at 18 months revealed abnormally thin myexamination at age 10, he was found to have bilateral pes cavus, elin sheaths with mild reduction in the number of myelinated fibers palpable ulnar nerves, muscle hypotonia, uniformly diminished (Figure 1) . No Wallerian degeneration was visible, and no macrostrength, areflexia, and diminished vibration sense. He was unable phages were seen. Rare rudimentary onion bulbs were seen by to stand without support and had a steppage gait that was unsteady. electron microscopy. The myelin sheaths were segmentally or cirNerve conduction studies demonstrated absence of both sensory cumferentially uncompacted (Figure 1 ). Occasionally relatively large and motor action potentials. No sural nerve biopsy was performed. axons were found that had no myelin, but instead were surrounded Patient 1049 was not clinically assessed prior to the evaluation by Schwann cells with copious cytoplasm (Figure 1 ). These findings of her children. Upon examination at age 34, she had bilateral pes were attributed mainly to a lack of development of proper myelin cavus with varus deformity. Muscle bulk and strength were normal. rather than the result of demyelination and failure of remyelination.
Deep tendon reflexes were present in the upper extremities, but A lumbar puncture revealed a cerebrospinal fluid (CSF) protein of diminished in the lower extremities. Both motor and sensory nerve 75 mg%. Additional NCV studies performed at ages 6 and 8 conconduction velocities were mildly delayed (motor: left peroneal, 31.5 firmed the finding at age 10 months of severe motor slowing (i.e., m/s; left ulnarm 44.2 m/s; sensory: left sural, 35.0 m/s; left median, age 6: left median, 9 m/s; left ulnar, 9 m/s; age 8: left median, 4 m/s; 47.1 m/s). The NCV findings could be consistent with a mild CMT1 left ulnar, 5 m/s). NCVs on her parents were normal.
phenotype. Patient 1022 was the product of an uncomplicated pregnancy Patient 1050 was not clinically assessed prior to the evaluation and delivery. She had delayed acquisition of motor milestones, did of his children. Upon examination at age 41, he had bilateral mild not walk until age 2, and had balance problems throughout childatrophy of the gastrocnemius muscles, pronounced distal hypesthehood. She was diagnosed with scoliosis at age 12. She had no sia for light touch, sharp and dull discrimination, elevated vibratory family history of neurological abnormalities, and her parents and thresholds in the feet, and markedly reduced deep tendon reflexes brother had normal NCVs. On presentation, she was found to have in the lower extremities. Both motor and sensory nerve conduction wide based unsteady gait, mild to moderate dextroscoliosis, atrophy velocities were mildly delayed (motor: left peroneal, 29.5 m/s; right of the interosseous muscles of the hands, and bilateral pes cavus ulnar, 44.4 m/s; sensory: left sural, 30.5 m/s; left median, 33.6 m/s). deformity. Deep tendon reflexes were absent, and there was loss
The NCV findings could be consistent with a mild CMT1 phenotype. of distal proprioception and vibratory sense in the upper and lower extremities bilaterally. There was distal limb weakness and deMolecular Analysis creased sensation distally to pin prick and light touch. CSF protein PCR amplification of the six coding exons of MPZ was performed was elevated to 169 mg%. NCV studies showed severe motor slowusing the primer sets and conditions previously described (Roa et ing (left ulnar nerve, 6 .1 m/s; left common peroneal nerve, 7.2 m/s), al., 1996). However, another exon 3 primer set that gives a slightly with marked delay in distal latencies and severe slowing in spinal larger PCR product was sometimes used, and the group of C. V. B. accessory nerve latency. Sensory nerve action potentials were absent in the left superficial peroneal, bilateral sural, left median, and used a different MPZ exon 5 primer set to perform the SSCP analysis.
